Nov 9, 2020 Cellectar Reports Third Quarter 2020 Financial Results and Provides a Corporate Update Learn More
Nov 5, 2020 Cellectar Biosciences’ CLR 131 Demonstrates Preliminary Activity in Phase I Study for Pediatric Brain and Solid Tumors Learn More
Sep 9, 2020 Cellectar Reports Data on CLR 131 Phase 2 CLOVER-1 Study in Triple Class Refractory Multiple Myeloma Patients Learn More